Valuation : Novartis AG

Market Cap 307B 265B 250B 228B 425B 29,165B 429B 2,955B 1,146B 14,829B 1,153B 1,128B 48,734B P/E 2026 *
22.9x
P/E 2027 * 19.5x
Enterprise Value 340B 293B 276B 252B 470B 32,269B 474B 3,269B 1,268B 16,406B 1,276B 1,248B 53,919B EV / Sales 2026 *
5.89x
EV / Sales 2027 * 5.46x
Free-Float
91.66%
Yield 2026 *
2.7%
Yield 2027 * 2.82%
1 day+0.27%
1 week+2.32%
Current month+6.54%
1 month+3.73%
3 months+15.29%
6 months+0.63%
Current year+19.82%
1 week 122.64
Extreme 122.64
132.6
1 month 121.02
Extreme 121.02
132.6
Current year 107.68
Extreme 107.68
132.6
1 year 96.03
Extreme 96.03
132.6
3 years 81.1
Extreme 81.1
132.6
5 years 72.84
Extreme 72.84
132.6
10 years 65.09
Extreme 65.09
132.6
Manager TitleAgeSince
Chief Executive Officer 50 31/01/2018
Director of Finance/CFO - 15/03/2026
Compliance Officer 58 13/04/2025
Director TitleAgeSince
Director/Board Member 67 31/12/2014
Director/Board Member 69 31/12/2015
Director/Board Member 61 31/12/2015
Date Insider Type Main position Quantity % Market Cap. Importance
18/05/26 Sell -5,200 0.0003%
04/05/26 Sell 6,800 0.0003%
17/02/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+0.27%+2.32%+29.33%+46.97% 307B
+0.01%-5.96%+58.36%+108.23% 1,034B
+1.48%+0.76%+55.34%+71.49% 654B
+0.67%-1.53%+24.39%+76.60% 459B
+0.49%-6.58%+34.20%+34.59% 343B
+0.12%-4.01%+1.06%+11.93% 251B
+1.08%+0.14%+53.92%+72.51% 237B
+2.64%-2.00%-17.38%-53.64% 202B
-0.21%+0.56%+32.43%+95.19% 186B
+1.65%+1.58%+17.21%-18.89% 163B
Average +0.61%-2.60%+28.89%+44.50% 383.43B
Weighted average by Cap. +0.58%-3.18%+38.28%+63.65%

Financials

2026 *2027 *
Net sales 57.65B 49.76B 46.84B 42.76B 79.8B 5,474B 80.45B 555B 215B 2,783B 216B 212B 9,147B 61.31B 52.92B 49.81B 45.47B 84.86B 5,822B 85.55B 590B 229B 2,960B 230B 225B 9,728B
Net income 13.95B 12.04B 11.33B 10.35B 19.31B 1,325B 19.47B 134B 52.07B 674B 52.38B 51.24B 2,214B 15.5B 13.38B 12.59B 11.5B 21.46B 1,472B 21.63B 149B 57.86B 748B 58.21B 56.94B 2,460B
Net Debt 32.68B 28.21B 26.55B 24.24B 45.23B 3,103B 45.6B 314B 122B 1,578B 123B 120B 5,185B 27.82B 24.01B 22.6B 20.63B 38.5B 2,642B 38.82B 268B 104B 1,343B 104B 102B 4,414B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
02/09/26 CHF 131.32 +0.27% 3,637,896
01/09/26 CHF 130.96 +6.25% 4,912,644
31/08/26 CHF 123.26 -0.39% 2,544,960
28/08/26 CHF 123.74 -0.72% 1,961,272
27/08/26 CHF 124.64 -2.00% 1,891,362
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
161.59USD
Average target price
154.40USD
Spread / Average Target
-4.45%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock